Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture

Prostate

Volumn 72, Issue 13, 2012, Pages 1478-1489

  Chen, Shuangling ^a   Principessa, Lorenzo ^a   Isaacs, John T ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

cancer initiating cells; human localized prostate cancer; prostaspheres

Indexed keywords

ANDROGEN; CALCIUM; GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER LOCALIZATION; CARCINOGENICITY; CELL ISOLATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SPHEROID; XENOGRAFT;

CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; HUMANS; MALE; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS; SPHEROIDS, CELLULAR;

EID: 84864877859     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22503     Document Type: Article

References (36)

1. Isaacs JT,. Prostate stem cells and benigh prostatic hyperplasia. Prostate 2008; 68: 1025-1034. (Pubitemid 351794166)
2. Goldstein AS, Stoyanova T, Witte ON,. Primative origins of prostate cancer: In vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells. Mol Oncol 2010; 4: 385-396.
3. Litvinov IV, De Marzo AM, Isaacs JT,. Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? J Clin Endocrinol Metab 2003; 88: 2972-2982. (Pubitemid 36877458)
4. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ,. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951. (Pubitemid 41713363)
5. Litvinov IV, Vander Griend DJ, Xu Y, Antony L, Dalrymple SL, Isaacs JT,. Low-calcium serum-free media selects for growth of normal prostate epithelial stem cells. Cancer Res 2006; 66: 8598-8607. (Pubitemid 44449174)
6. Gu G, Yuan J, Wills M, Kasper S,. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007; 67: 4807-4815. (Pubitemid 46910189)
7. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG,. Hierarchical organization of prostate cancer cells in xenograft tumors: The CD44 + alpha2beta1 + cell population is enriched in tumor-initiating cells. Cancer Res 2007; 67: 6796-6805. (Pubitemid 47105527)
8. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT,. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 2008; 68: 9703-9711.
9. Wei C, Guomin W, Yujun L, Ruizhe Q,. Cancer stem-like cells in human prostate carcimoma cells DU145-the seeds of the cell line? Cancer Biol Ther 2007; 6: e1-e6.
10. - prostate cells are early cancer progenitor/stem cells that provide a model for patients with pooor prognosis. Br J Cancer 2008; 98: 756-765. (Pubitemid 351272625)
11. Duhagon MA, Hurt EM, Sotelo-Silveira JR, Zhang X, Farrar WL,. Genomic profiling of tumor initiating prostaspheres. BMC Genomics 2010; 11: 324.
12. Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, Gurel B, Isaacs WB, Bova GS, Liu W, Xu J, Meeker AK, Netto G, De Marzo AM, Nelson WG, Yegnasubramanian S,. Androgen-induced TOP2B mediated double strand breaks and prostate cancer gene rearrangement. Nat Genet 2010; 42: 668-675.
13. Litvinov IV, Vander Griend DJ, Antony L, Dalrymple S, De Marzo AM, Drake CG, Isaacs JT,. Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells. Proc Natl Acad Sci USA 2006; 103: 15085-15090. (Pubitemid 44583168)
14. Vander Griend DJ, Litvinov IV, Isaacs JT,. Stabilizing androgen receptor in mitosis inhibits prostate cancer proliferation. Cell Cycle 2007; 6: 647-651. (Pubitemid 46535673)
15. deBono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI;, COU-AA-301 Investigators. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 2011; 364: 1995-2005.
16. Siegel R, Ward E, Brawley O, Jemal A,. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
17. Isaacs JT, Isaacs WB,. Androgen receptor outwits prostate cancer drugs. Nat Med 2004; 10: 26-27. (Pubitemid 38524693)
18. Edick MJ, Tesfay L, Lamb LE, Knudsen BS, Miranti CK,. Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death. Mol Biol Cell 2007; 18: 2481-2490. (Pubitemid 47025714)
19. Peehl DM, Sellers RG, Wong ST,. Defined medium for normal adult human prostatic stromal cells. In Vitro Cell Dev Biol Animal 1998; 34: 555-560. (Pubitemid 29071756)
20. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL, Nordeen SK, Miller GJ, Lucia MS,. Molecular characteristization of human prostate carcinoma celllines. Prostate 2003; 57: 205-225. (Pubitemid 37267805)
21. Troyer DA, Tang Y, Bedolla R, Adhvaryu SG, Thompson IM, Abboud-Werner S, Sun LZ, Friedrichs WE, deGraffenried LA,. Characterization of PacMetUT1, a recently isolated human prostate cancer cell line. Prostate 2008; 68: 883-892. (Pubitemid 351845219)
22. D'Antonio JM, Vander Griend DJ, Antony L, Ndikuyeze G, Dalrymple SL, Koochekpour S, Isaacs JT,. Loss of androgen receptor dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addition to androgen receptor signaling. PLoS One 2010; 5: e11475.
23. Gao J, Isaacs JT,. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells. Cancer Res 1998; 58: 3299-3306. (Pubitemid 28371069)
24. Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM, Reznikoff CA,. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res 1999; 59: 2957-2964. (Pubitemid 29283138)
25. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM,. Alpha-methylacyl-CoA racemase: A new molecular marker for prostate cancer. Cancer Res 2002; 62: 2220-2226. (Pubitemid 34411693)
26. Sedelaar JP, Isaacs JT,. Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone. Prostate 2009; 69: 1724-1729.
27. Pienta KJ, Abate-Schen C, Agus DB, Attar RM, Chung LW, Greenberg NM, Hahn WC, Isaacs JT, Navone NM, Peehl DM, Simons JW, Solit DB, Soule HR, VanDyke TA, Weber MJ, Wu L, Vessella RL,. The current state of preclinical prostate cancer animal models. Prostate 2008; 68: 629-639. (Pubitemid 351614641)
28. Berges RR, Vukanovic J, Epstein JI, CarMichel M, Cisek L, Johnson DE, Veltri RW, Walsh PC, Isaacs JT,. Implication of cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res 1995; 1: 473-480.
29. Tai S, Sun Y, Squires JM, Zhang H, Oh WK, Liang CZ, Huang J,. PC3 is a cell line characteristic of prostate small cell carcinoma. Prostate 2011; 71: 1668-1679.
30. Dalrymple S, Antony L, Xu Y, Uzgare AR, Arnold JT, Savaugeot J, Sokoll LJ, De Marzo AM, Isaacs JT,. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal vs. malignant prostate cells. Cancer Res 2005; 65: 9269-9279. (Pubitemid 41507993)
31. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A;, ERSPC Investigators. Screening and prostate cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-1328.
32. Boorjian SA, Eastham JA, Graefen M, et al. A critical analysis of the long-term impact of radical prostatecomy on cancer control and function outcomes. Eur Urol 2011; [Epub ahead of print].
33. Van Steenbrugge GJ, van Donger JJ, Reuvers PJ, de Jong FH, Schroeder FH,. Transplantable human prostatic carcinoma (PC-82) in athymic nude mice. I. Hormone dependence and the concentration of androgens in plasma and tumor tissue. Prostate 1987; 11: 195-210.
34. Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, Kung HJ, de Vere White RW, Gumerlock PH, Resnick MI, Amini SB, Pretlow TG,. CWR22: The first human prostate cancer xenograft with strongly androgen dependent and relapsed strains both in vivo and in soft agar. Cancer Res 1996; 56: 3024-3026.
35. Peehl DM, Stamey TA,. Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 1986; 22: 82-90. (Pubitemid 16167977)
36. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON,. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 2009; 70: 491-501.